Search

Search Constraints

You searched for: Author/Creator Amital, H.

Search Results

2. AB0281 Remission rates during golimumab treatment for rheumatoid arthritis are associated with differences in baseline disease states across geographic regions in the go-more study. (23rd January 2014)

3. AB0287 Decrease in 14–3–3eta protein levels is correlated with improvement of clinical disease activity in tofacitinib treated early rheumatoid arthritis patients. (12th June 2018)

4. AB0405 Baseline Predictors of Remission Rates during Golimumab Treatment for Rheumatoid Arthritis in the GO-MORE Study. (10th June 2014)